Drug Shortage Report for MIDAZOLAM INJECTION

Last updated on 2020-01-16 History
Report ID 93924
Drug Identification Number 02242904
Brand name MIDAZOLAM INJECTION
Common or Proper name Midazolam Injection
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) MIDAZOLAM
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 2mL
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-13
Estimated end date 2020-01-31
Actual end date 2019-12-04
Shortage status Resolved
Updated date 2020-01-16
Company comments Available December 4, 2019
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-01-16 French Compare
v5 2020-01-16 English Compare
v4 2020-01-16 English Compare
v3 2019-09-14 English Compare
v2 2019-09-13 French Compare
v1 2019-09-13 English Compare